AzTrials
AzTrials

AdiposityNCT04182542

Effects of Capacitive Radiofrequency at the Dermis and Adipose Tissue

A study testing Radiofrequency in people with Adiposity and Abdominal Obesity, run by Escola Superior de Tecnologia da Saúde do Porto at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Noninvasive fat reduction is a rapidly expanding field of cosmetic rejuvenation, as many patients are unwilling to suffer the downtime and healing associated with traditional invasive liposuction. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Adiposity, Abdominal Obesity
What is being tested?
Radiofrequency
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteBrazil
Study dates
2 Dec 2019to 31 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Women who will undergo plastic abdominoplasty surgery at the Clinical Hospital of the Federal UFTM.

Who cannot join

  • Sensitive and cognitive deficits
  • Aged less than 18 years
  • Metal implant at the application site
  • Pacemakers
  • Signs of infection
  • Circulatory disorders
  • Neoplasia.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Adriana mendonça

    Minas Gerais, Uberaba

Other trials in Brazil

About this study

Official title: Effects of Capacitive Radiofrequency at the Dermis and Adipose Tissue in the Abdominal Region

Noninvasive fat reduction is a rapidly expanding field of cosmetic rejuvenation, as many patients are unwilling to suffer the downtime and healing associated with traditional invasive liposuction. The radiofrequency (RF) device has been shown to be safe and effective for non-invasive fat reduction, as well as cutaneous enhancement and improvement of skin flaccidity (BOISNIC, et al., 2014).

Read the detailed description

In Brazil, the search for satisfaction with self-image has been increasing, since the profile of the population has been altered by cultural factors such as industrialized foods with high caloric content and sedentary lifestyle. These factors result in the accumulation of adipose tissue in typical and atypical places, caused by the imbalance of the energy balance, that is, a higher caloric intake when compared to the energy consumption.

Noninvasive fat reduction is a rapidly expanding field of cosmetic rejuvenation, as many patients are unwilling to suffer the downtime and healing associated with traditional invasive liposuction. The radiofrequency (RF) device has been shown to be safe and effective for non-invasive fat reduction, as well as cutaneous enhancement and improvement of skin flaccidity (BOISNIC, et al., 2014).

Radiofrequency emits focused electromagnetic waves that find resistance in the tissue, generating heat (KRUEGUER, LEVY and SADICK, 2012). This thermal energy affects the triple helix structure of the collagen, subsequently breaking the intramolecular hydrogen bonds, resulting in immediate contraction of the collagen and neocollagenesis in the dermis, without interfering in the epidermis.

This neocollagenesis and remodeling of collagen results in a visibly compacted and organized dermis. Skin enhancement is an important effect, since patients that search for non-invasive fat reduction usually also seek improvement in skin flaccidity. This represents a substantial improvement over currently available technology (BOISNIC, et al, 2014).

There is controversy regarding the mechanism of fat mobilization. Some authors, after observing human skin cultures at the end of the series of RF treatments found a profound effect on subcutaneous adipocytes. The analysis resulted in altered morphology and increased expression of the pyroptosis marker, APAF-1, suggesting that pyroptosis induced by irreversible electroporation is the mechanism of action. Adipocyte pyroptosis results in the release of triglycerides from disintegrated cell membranes, but in a delayed and gradual manner, allowing a slow and safe removal through the interstitial space and liquid transport systems, lymphatic vessels and other metabolic functions. There was no evidence of necrosis or inflammatory changes observed in adipocytes after treatments with BodyFX, a type of radiofrequency (BOISNIC, et al, 2014).

Other authors say that the increase in temperature caused by RF has physiological effects, such as increased cellular metabolism, increased vasodilation and blood supply and activation of branches of the autonomic nervous system releasing adrenaline and noradrenaline (BELENKY, et al., 2012; PUMPRALA, et al., 2015, MESSINA, et al., 2017, RYDDEN and ARNER, 2017). These effects culminate in the better efficacy of lipolysis, which is a biochemical process where lipid hydrolysis occurs.

The evaluation and application of the protocol will be performed in the therapeutic resources laboratory of the physiotherapy course of Federal University of Triângulo Mineiro- UFTM (whose coordinator is the researcher responsible for this study), the material will be collected at the Clinical Hospital of the UFTM surgical center and the preparation and analysis of the slides will be carried out in the pathology laboratory of UFTM.

The women who will undergo plastic abdominoplasty surgery at the Clinical Hospital of the UFTM will be invited to participate in the study. These women are in the electronic queue awaiting surgery and will be invited by the plastic surgery team.

The volunteers will receive radiofrequency (TECAR-BTL® device, with epidermal temperature above 40ºC) in the right infraumbilical abdominal region, with an application time of 10 minutes (2 minutes per applicator area) and the left region will be used as control. A single session will be held. After approximately 30 days of this application the material for histological analysis will be collected during the surgical act, at which point the skin and the subcutaneous tissue of the infraumbilical region are discarded by the surgeon.

Fragments collected during surgery will be fixed in Methacarn (60% methanol, 30% chloroform, 10% acetic acid) for 2 hours at room temperature (RT). The slides will be made by the department of general pathology of the Federal University of the Triângulo Mineiro. Samples will be dehydrated in ethanol, diaphonized in xylol and embedded in paraffin. Histological sections of 5 μm thickness will be obtained in microtome (Jung) and placed on pre-coated sheets with polylysine. The histological sections will be stained with hematoxylin and eosin, Picro-sirius and Verhoeff. By the staining of Hematoxylin-Eosin will be analyzed the general morphology of the tissue including the quantity and volume of the adipose vacuoles, Picro-sirius the presence and morphology of the collagen fibers and Verhoeff the elastic fibers.

Blades stained by Hematoxylin-Eosin, Picro-sirius and Verhoeff will be visualized with a 20x objective. The images will be captured by a common light microscope and analyzed by the Axion Vision Automatic Image Analyzer System.

In this way the field to be quantified will be captured, photographed through a camera attached to the microscope and to the computer for image scanning. Images will be saved in TIFF format. All blade fields will be photographed and saved.

After the fields are saved, the Image J® program will be used to improve them, using the illumination reference so that they all have the same quality.

The percentage of collagen, elastic fibers and the analysis of the amount and volume of the adipose vacuole will be marked by the Image J® program and registered in a Microsoft Excel worksheet.

Being tested
Radiofrequency
Keywords
Capacitive Radiofrequency, Abdominal Adipose Tissue
Medical subject headings
Obesity, Obesity, Abdominal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RadiofrequencyDevice

    Also called Radiofrequency treatment

    The volunteers will receive radiofrequency (TECAR-BTL® device, with epidermal temperature above 40ºC) in the right infraumbilical abdominal region, with an application time of 10 minutes (2 minutes per applicator area) and the left region will be used as control. A single session will be held. After approximately 30 days of this application the material for histological analysis will be collected during the surgical act, at which point the skin and the subcutaneous tissue of the infraumbilical region are discarded by the surgeon.

Study groups in NCT04182542
Study groupRoleWhat they receive
RFExperimentalThe right side will be treated with radiofrequency
Receives: Device: Radiofrequency
NINo interventionThe left side will not receive treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. percentage of collagen, elastic fibers and the analysis of the amount and volume of the adipose vacuole

    The percentage of collagen, elastic fibers and the analysis of the amount and volume of the adipose vacuole will be marked by the Image J® program and registered in a Microsoft Excel worksheet- For the variables percentage of collagen, elastic fibers, number of fibroblasts and number of adipocytes will be performed the normality test with Shapiro Wilk. The paired t test will be used when data are normal and Wilcoxon when not normal. The differences observed will be considered significant when the probability of rejection of the null hypothesis is less than 0.05.

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2019
  2. Study start2 Dec 2019
  3. Primary completion24 Apr 2020
  4. Study completion31 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04182542
Sponsor's protocol ID
AN-010
Status last verified
Sep 2020
First submitted
26 Nov 2019
Last updated
4 Sep 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Belenky I, Margulis A, Elman M, Bar-Yosef U, Paun SD. Exploring channeling optimized radiofrequency energy: a review of radiofrequency history and applications in esthetic fields. Adv Ther. 2012 Mar;29(3):249-66. doi: 10.1007/s12325-012-0004-1. Epub 2012 Feb 29.

    PubMed 22382873
  • Boisnic S, Divaris M, Nelson AA, Gharavi NM, Lask GP. A clinical and biological evaluation of a novel, noninvasive radiofrequency device for the long-term reduction of adipose tissue. Lasers Surg Med. 2014 Feb;46(2):94-103. doi: 10.1002/lsm.22223.

    PubMed 24535760
  • Krueger N, Levy H, Sadick NS. Safety and efficacy of a new device combining radiofrequency and low-frequency pulsed electromagnetic fields for the treatment of facial rhytides. J Drugs Dermatol. 2012 Nov;11(11):1306-9.

    PubMed 23135079

Questions about this trial

What is this clinical trial studying?

A study testing Radiofrequency in people with Adiposity and Abdominal Obesity, run by Escola Superior de Tecnologia da Saúde do Porto at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

percentage of collagen, elastic fibers and the analysis of the amount and volume of the adipose vacuole (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04182542, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in